Mouse models for therapeutic vaccination against hepatitis B virus

[1]  Zheng Zhang,et al.  Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages , 2014, PLoS pathogens.

[2]  L. Su,et al.  A mouse model for HBV immunotolerance and immunotherapy , 2013, Cellular and Molecular Immunology.

[3]  P. Roques,et al.  Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from mauritius island , 2013, Hepatology.

[4]  M. Tschapka,et al.  Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes , 2013, Proceedings of the National Academy of Sciences.

[5]  Jia Liu,et al.  Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model , 2013, PLoS pathogens.

[6]  M. Odenthal,et al.  Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection , 2013, Nature Immunology.

[7]  M. Bourgine,et al.  Adeno-Associated Virus-Mediated Gene Transfer Leads to Persistent Hepatitis B Virus Replication in Mice Expressing HLA-A2 and HLA-DR1 Molecules , 2013, Journal of Virology.

[8]  U. Protzer,et al.  A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice. , 2013, Vaccine.

[9]  D. Busch,et al.  Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice , 2012, Hepatology.

[10]  M. Bility,et al.  Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis , 2012, Nature Protocols.

[11]  J. Hampe,et al.  Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity , 2012, Nature Medicine.

[12]  M. Heikenwalder,et al.  Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice. , 2012, Gastroenterology.

[13]  Percy A. Knolle,et al.  Living in the liver: hepatic infections , 2012, Nature Reviews Immunology.

[14]  M. Manns,et al.  [Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. , 2011, Zeitschrift fur Gastroenterologie.

[15]  P. Schirmacher,et al.  Sequential control of hepatitis B virus in a mouse model of acute, self‐resolving hepatitis B , 2011, Journal of viral hepatitis.

[16]  M. Imamura,et al.  Animal model for study of human hepatitis viruses , 2011, Journal of gastroenterology and hepatology.

[17]  C. Flechtenmacher,et al.  Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with Dendritic Cells pulsed by HBVsvp , 2011 .

[18]  Percy A. Knolle,et al.  Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.

[19]  F. Chisari,et al.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. , 2010, The Journal of clinical investigation.

[20]  I. Verma,et al.  Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model , 2007, Proceedings of the National Academy of Sciences.

[21]  Ding‐Shinn Chen,et al.  An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection , 2006, Proceedings of the National Academy of Sciences.

[22]  T. Volz,et al.  Animal models for the study of HBV replication and its variants. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[23]  P. Marion,et al.  Entecavir Therapy Combined with DNA Vaccination for Persistent Duck Hepatitis B Virus Infection , 2003, Antimicrobial Agents and Chemotherapy.

[24]  F. Chisari,et al.  Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Zauberman,et al.  The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases. , 2002, Current opinion in molecular therapeutics (Print).

[26]  A. Berrebi,et al.  Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection , 2001, European journal of immunology.

[27]  H. Schaller,et al.  Transfer of Hepatitis B Virus Genome by Adenovirus Vectors into Cultured Cells and Mice: Crossing the Species Barrier , 2001, Journal of Virology.

[28]  C. Rogler,et al.  Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus , 2001, Hepatology.

[29]  E. Galun,et al.  Preclinical Evaluation of Two Human Anti–Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV‐Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees , 2000, Hepatology.

[30]  E. Galun,et al.  Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen‐specific antibodies in the Trimera mouse , 2000, Hepatology.

[31]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[32]  E. Galun,et al.  The hepatitis B virus–trimera mouse: A model for human HBV infection and evaluation of anti‐HBV therapeutic agents , 1999, Hepatology.

[33]  M. Onji,et al.  Hepatitis B virus (HBV)‐transgenic mice as an investigative tool to study immunopathology during HBV infection , 1998, International journal of experimental pathology.

[34]  F. Chisari,et al.  High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.

[35]  F. Chisari,et al.  Immunology and the liver , 1991, Hepatology.

[36]  R. Palmiter,et al.  Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator , 1990, Cell.

[37]  J. Miyazaki,et al.  Expression and replication of hepatitis B virus genome in transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Babinet,et al.  Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Summers,et al.  Experimental transmission of duck hepatitis B virus. , 1983, Virology.

[40]  J. Summers,et al.  A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Medawar,et al.  ‘Actively Acquired Tolerance’ of Foreign Cells , 1953, Nature.

[42]  F. Burnet,et al.  The failure of antibody production in the chick embryo. , 1950, The Australian journal of experimental biology and medical science.